Crescent Capital BDC Inc (CCAP)

Crescent Capital BDC, Inc. is a closed-end fund listed on NASDAQ and structured as a business development company. The fund focuses on direct investing and is oriented toward private equity and buyout opportunities, along with lending activities. Its stated mandate centers on middle-market investments, with an emphasis on opportunities in the United States. The listed security is common stock in an investment fund vehicle rather than shares of a conventional operating company.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Dividend Yield Next Earnings Date Market Cap Payout Ratio
NASDAQ-CCAP
Not available
$12.25
25.5% Upside
Undervalued
Fair
November 30, 2026
December 15, 2026
1.2%
November 11, 2026
359.6 M
-2,056.0%
Valuation • Fair Value

Crescent Capital BDC Inc (NASDAQ-CCAP) Fair Value by Valuation Model

Review the valuation references currently available for Crescent Capital BDC Inc (NASDAQ-CCAP).

Primary Valuation Read

Fair Value

Not available

Data is currently unavailable.

Analyst Price Target

$12.25

Analysts imply upside of 25.5%.

How to read these valuation models

Use the available valuation reference for Crescent Capital BDC Inc (NASDAQ-CCAP) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Crescent Capital BDC Inc (NASDAQ-CCAP)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

156.4 M

Current operating scale indicator.

EBITDA

0 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Crescent Capital BDC Inc (NASDAQ-CCAP) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Crescent Capital BDC Inc (NASDAQ-CCAP)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Crescent Capital BDC Inc (NASDAQ-CCAP). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Crescent Capital BDC Inc (NASDAQ-CCAP)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 11, 2026

Days to Earnings

50

Dividend Payment Date

December 15, 2026

Ex-Dividend Date

November 30, 2026

Dividend Yield

1.2%

Current income yield reference.

Payout Ratio

-2,056.0%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Crescent Capital BDC Inc (NASDAQ-CCAP), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Crescent Capital BDC Inc (NASDAQ-CCAP) Stock Forecast & Technical Outlook

Review Crescent Capital BDC Inc (NASDAQ-CCAP) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Crescent Capital BDC Inc (NASDAQ-CCAP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Crescent Capital BDC Inc (NASDAQ-CCAP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Crescent Capital BDC Inc (NASDAQ-CCAP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Crescent Capital BDC Inc (NASDAQ-CCAP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Crescent Capital BDC Inc (NASDAQ-CCAP) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Crescent Capital BDC Inc (NASDAQ-CCAP)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Hold

Based on the available recommendation mix, Crescent Capital BDC Inc (NASDAQ-CCAP) has a Hold consensus, with 1 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 5
Sell 0
FAQ Fast Investor Answers

Crescent Capital BDC Inc (NASDAQ-CCAP) Stock FAQ

Data-supported answers about Crescent Capital BDC Inc (NASDAQ-CCAP), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
Not available
No reliable estimate from the currently supported inputs
Analyst Target
$12.25
Implied upside 25.5%
Financial Health
Fair
Current financial-health read

A reliable fair value estimate is not currently available for Crescent Capital BDC Inc (NASDAQ-CCAP). This generally means the latest dataset does not contain enough valid inputs for the valuation models supported by PriceToWorth. The site does not substitute zero or publish an unsupported estimate; availability may change when updated financial data or applicable model inputs become available.

The available analyst price target for Crescent Capital BDC Inc (NASDAQ-CCAP) is $12.25. The analyst target implies estimated upside of 25.5%.

The current financial health read for Crescent Capital BDC Inc (NASDAQ-CCAP) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Crescent Capital BDC Inc (NASDAQ-CCAP) is November 11, 2026.

Based on the current data, dividend yield is 1.2%, ex-dividend date is November 30, 2026, payment date is December 15, 2026.

The current market capitalization listed for Crescent Capital BDC Inc is 359.6 M.

The ticker symbol for Crescent Capital BDC Inc is NASDAQ-CCAP, and the stock is listed on NASDAQ.

Crescent Capital BDC Inc (NASDAQ-CCAP) is listed on NASDAQ.